TAXIS PHARMACEUTICALS INC — Federal Contracts, Awards & Government Contractor Profile

About TAXIS PHARMACEUTICALS INC

TAXIS Pharmaceuticals is a clinical-stage company developing investigational anti-resistance therapies to address antimicrobial resistance (AMR). Their approach targets the root causes of bacterial survival through novel mechanisms such as FtsZ inhibitors, efflux pump inhibitors, and dihydrofolate reductase inhibitors.

Development of investigational therapies to combat antimicrobial resistanceResearch on novel mechanisms of action for anti-resistance agentsPreclinical and clinical development of antibiotic candidatesEfflux pump inhibitors to enhance existing antibioticsFtsZ inhibitors targeting bacterial cell divisionDihydrofolate reductase inhibitors for treating resistant gonorrhea

Is this your company?

Claim TAXIS PHARMACEUTICALS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim TAXIS PHARMACEUTICALS INC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.